In a new Illumina Genomics Podcast (Episode 53), Jean-François Brepson discusses the company’s vision of the impact of NGS on the diagnosis of infectious disease with the development of iDTECT™ blood, the company’s CE-IVD NGS-based test that supports a more personalized approach to antimicrobial stewardship and the fight against antimicrobial resistance. The podcast, entitled “NGS and New Frontiers in Infectious Disease” is available at http://bit.ly/illumina-pathoquest-podcast.

.